The Wegovy escalation model Most compounded semaglutide protocols mirror the FDA-approved Wegovy escalation schedule, even though compounded versions are not FDA-approved themselves
According to standard clinical guidance and Omzo's own eligibility framing, licensed clinicians evaluating GLP-1 candidacy typically consider factors like body mass index, medical history, existing conditions (particularly thyroid disease, pancreatitis, or other contraindications for GLP-1 medications), current medications, and personal health goals
The website is easy to use, and delivery is fast
After youre done injecting, dont throw the needles in the trash
Common side effects may include nausea, upset stomach, diarrhea, and headache